Drug class
Ovine digoxin-specific Fab antibody fragments; antidote for cardiac glycoside toxicity
Mechanism of action
Fab fragments bind free digoxin with high affinity, reducing the unbound fraction available to bind the sodium-potassium ATPase. Fab–digoxin complexes are cleared through renal and reticuloendothelial pathways.
General use cases
- Treatment of life-threatening or potentially life-threatening digoxin toxicity or overdose; product-specific monitoring and dose calculation are required
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
